Efficacy of decompressive craniectomy on long-term functional outcomes in patients with severe acquired brain injury: a systematic review and meta-analysis.
{"title":"Efficacy of decompressive craniectomy on long-term functional outcomes in patients with severe acquired brain injury: a systematic review and meta-analysis.","authors":"Lingling Guo, Jinchao Zhao","doi":"10.1080/00207454.2026.2673871","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To evaluate the efficacy of decompressive craniectomy (DC) on long-term functional outcomes in patients with severe acquired brain injury (ABI) through systematic review and meta-analysis.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis of studies from 2010 to 2025. Nine studies (5 RCTs and 4 cohorts) with 3866 patients were included after quality assessment. Analysis was performed using RevMan 5.4.</p><p><strong>Results: </strong>DC significantly improved functional outcomes at 12 months (OR = 3.63, 95% CI: 1.45-9.10) and reduced 12-month mortality (OR = 0.44, 95% CI: 0.21-0.90), despite high heterogeneity for mortality. No significant benefit was found for 6-month functional outcomes or complication rates. Subgroup analyses indicated that the survival benefit was more pronounced in Asian populations, and functional improvement was significant for both traumatic and non-TBI patients.</p><p><strong>Conclusions: </strong>DC provides significant long-term benefits for functional outcomes and survival in severe ABI patients, without increasing short-term complications. Its efficacy varies by ethnicity and etiology, suggesting a need for personalized treatment decisions.</p>","PeriodicalId":14161,"journal":{"name":"International Journal of Neuroscience","volume":" ","pages":"1231-1240"},"PeriodicalIF":1.7000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00207454.2026.2673871","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/6 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To evaluate the efficacy of decompressive craniectomy (DC) on long-term functional outcomes in patients with severe acquired brain injury (ABI) through systematic review and meta-analysis.
Methods: We conducted a systematic review and meta-analysis of studies from 2010 to 2025. Nine studies (5 RCTs and 4 cohorts) with 3866 patients were included after quality assessment. Analysis was performed using RevMan 5.4.
Results: DC significantly improved functional outcomes at 12 months (OR = 3.63, 95% CI: 1.45-9.10) and reduced 12-month mortality (OR = 0.44, 95% CI: 0.21-0.90), despite high heterogeneity for mortality. No significant benefit was found for 6-month functional outcomes or complication rates. Subgroup analyses indicated that the survival benefit was more pronounced in Asian populations, and functional improvement was significant for both traumatic and non-TBI patients.
Conclusions: DC provides significant long-term benefits for functional outcomes and survival in severe ABI patients, without increasing short-term complications. Its efficacy varies by ethnicity and etiology, suggesting a need for personalized treatment decisions.
期刊介绍:
The International Journal of Neuroscience publishes original research articles, reviews, brief scientific reports, case studies, letters to the editor and book reviews concerned with problems of the nervous system and related clinical studies, epidemiology, neuropathology, medical and surgical treatment options and outcomes, neuropsychology and other topics related to the research and care of persons with neurologic disorders. The focus of the journal is clinical and transitional research. Topics covered include but are not limited to: ALS, ataxia, autism, brain tumors, child neurology, demyelinating diseases, epilepsy, genetics, headache, lysosomal storage disease, mitochondrial dysfunction, movement disorders, multiple sclerosis, myopathy, neurodegenerative diseases, neuromuscular disorders, neuropharmacology, neuropsychiatry, neuropsychology, pain, sleep disorders, stroke, and other areas related to the neurosciences.